Royal Bank of Canada

Executive Summary

HOLD, High conviction. Rated HOLD, High conviction. Royal Bank of Canada is delivering strong numbers, with FY2025 revenue up 9.1%, EPS up 10.8%, and a clean streak of quarterly EPS beats, capped by Q3 2026 record earnings of $6.0B. The issue is price, not business quality: at $206.09, the shares sit 5.7% below the 52-week high and above the quant base case only modestly, leaving limited room for error as management merely reiterated, not raised, FY2026 guidance.

Investment Thesis

RY is a good bank, not a great stock entry. The operating picture is hard to fault: FY2025 revenue reached $98.1B, up 9.1%, EPS rose 10.8% to $10.08, and management has now posted 8 straight quarterly EPS beats. The latest quarter was not just cosmetically strong either. Q3 2026 delivered record earnings of $6.0B, with strength in Wealth, Capital Markets, Commercial Banking, and improved loan momentum. Commercial deposits rose 9% YoY, sequential loan growth improved to 1.2%, and management maintained its full-year impaired PCL range while calling credit trends stable to improving.

The problem is what an investor is paying for that quality today. At $206.09, the stock trades at 17.91x earnings, well above the 14.4x average peer P/E. That premium can be defended when earnings revisions are moving up sharply or guidance is being raised. Neither is true here. After a record quarter, management still only reiterated FY2026 targets, with the CFO saying, "To conclude, we reiterate our full year targets while remaining mindful of the evolving macro environment." That matters because the stock is already 11.5% above its 200-day average and only 5.7% below its 52-week and 5-year high. This is not a washed-out setup.

The core debate is whether forward earnings power can outrun the valuation premium. There are reasons for optimism. Canadian Banking margins are expected to be relatively stable in Q4, all-bank NII ex-trading is still guided to grow mid-single-digit in FY2026, expense growth is also mid-single-digit, and operating leverage should stay positive. AI could add real efficiency, with management targeting $700M to $1B of enterprise value by FY2027. But those benefits are partly future-state and the latest quarter still showed some pressure under the hood, including a 4 bps decline in all-bank NIM ex-trading and EBITDA margin falling to 20.0%.

The case depends on three things: stable credit, continued execution in Wealth and Capital Markets, and proof that efficiency gains from HSBC integration and AI actually drop through to returns. Management has earned the benefit of the doubt on execution. The stock has not earned a larger premium from here. HOLD is the disciplined call.

Key Metrics

Financial Strength

The balance sheet read is solid for a large diversified bank, even if raw leverage statistics look high in isolation. Debt/Equity of 2.88 and Debt/EBITDA of 14.55 are normal enough within banking structure and are offset by a strong current ratio of 4.85, durable profitability, and management's continued ability to repurchase stock aggressively. The cleaner read is in earnings capacity and capital flexibility: profitability is high, credit trends are stable, and the expected ~10 bps CET1 uplift from the Moneris sale adds another buffer. The one caution is cash flow optics, where bank FCF can be noisy and the low cash flow quality score of 40 argues against paying materially more than the current premium multiple.

Competitive Position

RY's moat is built on domestic scale, low-cost funding, deep customer relationships across retail, commercial, wealth, and capital markets, and the regulatory barriers that make Canadian banking hard to disrupt at scale. The moat is durable because large incumbents still control distribution, compliance infrastructure, and balance-sheet capacity, but it is not widening quickly because mortgage pricing and term-deposit competition remain intense. AI should strengthen the moat modestly through lower servicing and underwriting costs, not transform it.

Management & Guidance

Management's FY2026 guide remains measured: mid-single-digit all-bank NII ex-trading growth, mid-single-digit expense growth, positive all-bank operating leverage, 1%-2% Canadian Banking operating leverage, and a 21%-23% non-TEB tax rate, toward the higher end. The notable point is not the guide itself but the fact that it was reiterated after a record quarter rather than raised. That said, this team has a strong pattern of underpromising and then beating, with 8 straight EPS beats, and current commentary on credit was steady, including, "We expect our overall full year 2026 provisions on impaired loans to remain within the range we previously guided to." Guidance looks credible, but not obviously conservative enough to unlock major upside from an already elevated share price.

Segment Analysis

• Canadian Banking (N/A): Core earnings anchor, with management guiding relatively stable Q4 margins and 1%-2% operating leverage for FY2026 despite mortgage and term-deposit competition.
• Wealth Management (N/A): A major growth and fee-income contributor, highlighted as an outperformance area in Q3 2026 on client activity and constructive markets.
• Capital Markets (N/A): Delivered record revenue and net income in Q3 2026, but also drove some mix-related NIM pressure and included $120M of extra provisions on a utility exposure.
• Commercial Banking (N/A): Healthy momentum, with commercial deposits up 9% YoY and sequential loan growth improving to 1.2%.
• Insurance (N/A): The weak spot in the latest quarter, with net income down 20% YoY because of tougher prior-year longevity and reinsurance comparisons.

Capital Allocation

Capital allocation has been disciplined. The bank is still returning meaningful capital, with 5.6M shares repurchased for $1.6B in Q3 and $4.1B of buybacks in the latest cash flow data, alongside $1.7B of dividends. Capex is light at $0.5B, and management is also unlocking capital through the Moneris sale, expected to add about 10 bps CET1 in Q1 2027, which supports further flexibility without stretching the balance sheet.

Management Execution & Track Record

Management has earned credibility. On the 2024 Q4 call, RBC guided to mid- to high-single-digit FY2025 NII ex-trading growth, mid-single-digit expense growth, 1%-2% Canadian Banking operating leverage, and mid-30s bps credit losses, while warning that peak loss rates would come in 2H FY2025. Since then, the bank delivered FY2025 revenue growth of 9.1%, EPS growth of 10.8%, and a clean beat cadence through 8 straight quarters, suggesting it managed through the cautious credit outlook better than feared. The direction has not changed materially: the current FY2026 framework still calls for mid-single-digit NII ex-trading growth, mid-single-digit expense growth, and positive operating leverage, while credit trends are now described as stable to improving. That consistency, plus delivered HSBC savings of $400M+ run-rate at the time and ongoing buybacks, supports the view that this is a credible operating team, even if they remain conservative in formally raising guidance.

Positioning & Flows

Ownership is stable and institutional, with the top 3 holders controlling 36.6%, while insider ownership is 0.0%, typical for a large bank but not a special signal. Short interest is low at 0.38% of shares outstanding, or 5.26M shares and 3.7 days-to-cover, so there is little fuel for a squeeze or a strong contrarian long setup. Options positioning is slightly less friendly near term, with negative GEX and a zero-gamma level at $211.2, just above spot, which can amplify moves around earnings but does not change the fundamental view.

Bull Case

• FY2025 revenue of $98.1B rose 9.1% YoY, and net margin reached 29.4%, showing strong earnings conversion across the franchise.
• Execution has been consistent: RY beat EPS estimates in 8 straight quarters, with upside ranging from +0.9% to +18.2%, which supports confidence in management's forecasting discipline.
• Q3 2026 was genuinely strong, with record earnings of $6.0B and outperformance in Capital Markets and Wealth, while commercial deposits grew 9% YoY and sequential loan growth improved to 1.2%.
• Credit trends are not deteriorating at the margin, with management saying provisions on impaired loans should remain within prior FY2026 guidance and sector data shows credit-card delinquency at 2.85%, easing.

Bear Case

• The stock trades at 17.91x earnings, a 24% premium to the 14.4x peer average, which is hard to justify when management reiterated rather than raised FY2026 targets after a record quarter.
• Underlying margin momentum softened in Q3 2026: EBITDA margin was 20.0%, down 310 bps QoQ and 200 bps YoY, and all-bank NIM ex-trading fell 4 bps sequentially.
• Insurance weakened, with net income down 20% YoY, and Capital Markets added $120M of provisions tied to a utility exposure, showing that credit costs can still surprise in pockets.
• Cash flow quality is the weakest quality sub-score at 40, and reported FCF was negative $20.5B in one dataset, a reminder that headline bank cash flow metrics can be lumpy and should not be overread as pure distributable cash.

Valuation & Price Target

Engine price target $217.52 (+5.5% vs current), High confidence.

• P/E Multiple: $230.79 (28% weight)
• PEG (growth-adjusted): $217.03 (20% weight)
• P/S Multiple: $186.17 (20% weight)
• Quality-adjusted: $251.07 (20% weight)
• DCF: $182.83 (12% weight)

The rating aligns with the quant baseline HOLD (High conviction) for the same basic reason: $217.52 fair value offers only 5.5% upside from $206.09. The business arguably deserves better than a bearish stance because EPS is compounding, credit is stable, and management keeps beating expectations, but a bullish divergence from the quant call would require either a more attractive entry or evidence that FY2026 earnings power is materially above reiterated guidance. Sell-side consensus is also Hold, but that signal is thin with only 1 firm and is not the basis for the view.

Risk Assessment

Risk score 32/100 (Low). The biggest risk is valuation compression, because a move from 17.91x P/E toward the 14.4x peer average would likely outweigh another year of mid-single-digit NII growth.

The Bottom Line

Rated HOLD, High conviction. RY is one of the better-run North American banks, and the operating trend remains healthy, but the market knows it. At 17.91x earnings and just 5.7% off the high, the stock needs either a guidance raise or a clearer step-up in forward earnings power to justify a more aggressive stance. A pullback, or evidence that AI, HSBC synergies, and stable credit can drive earnings above the current framework, would improve the setup. A downgrade would require either credit slippage beyond guided ranges or sustained margin erosion without offsetting fee growth.